Manuscript Submission Guidelines:

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit the Journal’s submission site https://peerreview.sagepub.com/cmd to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.

Only manuscripts of sufficient quality that meet the aims and scope of International Journal of Clinical Metabolism and Diabetes  will be reviewed.

There are no fees payable to submit or publish in this Journal. Open Access options are available - see section 3.3 below.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for rst publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that  International Journal of Clinical Metabolism and Diabetes will consider submissions of papers that have been posted on preprint servers; please alert the Editorial O   ce when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated eld in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the Journal. If the article is accepted for publication, the author may re-use their work according to the Journal's author archiving policy.

If your paper is accepted, you must include a link on your preprint to the nal version of your paper.

If you have any questions about publishing with Sage, please visit the Sage Journal Solutions Portal.

1. What do we publish?

1.1 Aims & Scope

1.2 Article types

1.3 Writing your paper

1.3.1 Making your article discoverable

2. Editorial policies

2.1 Peer review policy

2.2 Authorship

2.3 Acknowledgements

2.3.1 Writing assistance

2.4 Funding

2.5 Declaration of con icting interests

2.6 Research ethics and patient consent

2.7 Clinical trials

2.8 Reporting guidelines

2.9 Research data

3. Publishing policies

3.1 Publication ethics

3.1.1 Plagiarism

3.1.2 Prior publication

3.2 Contributor’s publishing agreement

3.3 Open access and author archiving

4. Preparing your manuscript for submission

4.1 Formatting

4.2 Artwork, gures and other graphics

4.3 Supplemental material

4.4 Reference style

5. Submitting your manuscript

5.1 ORCID

5.2 Information required for completing your submission

5.3 Permissions

6. On acceptance and publication

6.1 Sage Production

6.2 Online First publication

6.3 Access to your published article

6.4 Promoting your article

7. Further information

1. What do we publish?

1.1 Aims & Scope

Before submitting your manuscript to International Journal of Clinical Metabolism and Diabetes, please ensure you have read the Aims & Scope.

1.2 Article types

• International Journal of Clinical Metabolism and Diabetes invites the following types of papers:
• Original articles
• Narrative reviews
• Systematic reviews and Meta analysis
• Case Reports
• Perspectives
• Letters to the editor

The word limit for original articles and review is 3000 excluding references and an abstract (structured format) of not more than 250 words. Editorials, perspectives and case reports should not be more than 1500 words; and letters should be restricted to 700 words. A graphical abstract will be preferred.

There is no arbitrary limit on the number of references.

Return to Top

1.3 Writing your paper

The Sage Author Gateway has some general advice on how to get published, plus links to further resources.

1.3.1 Make your article discoverable

For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online.

Return to Top

2. Editorial policies

2.1 Peer review policy

International Journal of Clinical Metabolism and Diabetes adheres to a rigorous doubleanonymized reviewing policy in which the identity of both the reviewer and author are always concealed from both parties. Each manuscript is reviewed by at least two referees.

•  All manuscripts are reviewed initially by the Editors and only those papers that meet the editorial standards of the journal, and t within the aims and scope of the journal, will be sent for outside review.
•  Decisions on manuscripts will be taken as rapidly as possible. Authors should expect to have the reviewer’s comments within approximately 6 weeks. In general, Editors will seek advice from two or more expert reviewers about the content and presentation of submitted articles.

All manuscripts are reviewed initially by the Editors and only those papers that meet the editorial standards of the journal, and t within the aims and scope of the journal, will be sent for outside review.

In general, Editors will seek advice from two or more expert reviewers about the content and presentation of submitted articles. The Editor will consider the reviewers’ recommendations and assess whether a contribution should be accepted for publication subject to stipulated changes or that the author(s) should be requested to revise the manuscript substantially or that the manuscript is not yet fully developed.

Decisions on manuscripts will be taken as early as possible. Authors can expect Editorial decision within 45 days from submission.

The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.

Return to Top

2.2 Authorship

Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

The list of authors should include all those who can legitimately claim authorship. This is all those who:

1. Made a substantial contribution to the concept or design of the work; oracquisition, analysis or interpretation of data,
2. Drafted the article or revised it critically for important intellectual content,
3. Approved the version to be published,
4. Each author should have participated su ciently in the work to take public responsibility for appropriate portions of the content.

Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the

International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship. Return to Top

2.3 Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.

2.3.1 Writing assistance

Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.

2.4 Funding

International Journal of Clinical Metabolism and Diabetes requires all authors to acknowledge their funding in a consistent fashion under a separate heading.  Please visit the Funding Acknowledgements page on the Sage Journal Author Gateway to con rm the format of the acknowledgment text in the event of funding, or state that: This research received no speci c grant from any funding agency in the public, commercial, or not-for-pro t sectors. Return to Top

2.5 Declaration of conflicting interests

It is the policy of International Journal of Clinical Metabolism and Diabetes to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

Please ensure that a ‘Declaration of Con icting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no con ict exists, please state that ‘The Author(s) declare(s) that there is no con ict of interest’.

For guidance on con ict of interest statements, please see the ICMJE recommendations.

Return to Top

2.6. Research ethics and patient consent

Medical research involving human subjects must be conducted according to the World

Medical Association Declaration of Helsinki

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant ethics committee or institutional review board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s con dentiality. The Journal requests that you con rm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The con rmatory letter may be uploaded with your submission as a separate le.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

           All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

2.7. Clinical trials

International Journal of Clinical Metabolism and Diabetes endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of rst patient enrolment. However, consistent with the AllTrials campaign, retrospectively

registered trials will be considered if the justi cation for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.

2.8. Reporting guidelines

The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT ow chart as a cited gure and the completed CONSORT checklist should be uploaded with your submission as a supplementary le. Systematic reviews and meta-analyses should include the completed PRISMA ow chart as a cited gure and the completed PRISMA checklist should be uploaded with your submission as a supplementary le. The EQUATOR wizard can help you identify the appropriate guideline.

CONSORT Flowchart Example

PRISMA owchart for new systematic reviews which included searches of databases and registers only

*Consider, if feasible to do so, reporting the number of records identi ed from each database or register searched (rather than the total number across all databases/registers). **If automation tools were used, indicate how many records were excluded by a human and how many were excluded by automation tools.

Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives Return to Top

2.9. Research data

At Sage we are committed to facilitating openness, transparency and reproducibility of research. Where relevant, International Journal of Clinical Metabolism and Diabetes encourages authors to share their research data in a suitable public repository subject to ethical considerations and where data is included, to add a data accessibility statement in their manuscript le. Authors should also follow data citation principles. For more information please visit the Sage Author Gateway, which includes information about Sage’s partnership with the data repository Figshare.

Return to Top

3.Publishing Policies

3.1 Publication ethics

Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the Sage Author Gateway

3.1.1 Plagiarism

International Journal of Clinical Metabolism and Diabetes and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insu        cient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

3.1.2 Prior publication

If material has been previously published it is not generally acceptable for publication in a Sage journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the Sage Author Gateway or if in doubt, contact the Editor at the address given below.

Return to Top

3.2 Contributor’s publishing agreement

Before publication, Sage requires the author as the rights holder to sign a Journal

Contributor’s Publishing Agreement. Sage’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants Sage the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than Sage. In this case copyright in the work will be assigned from the author to the society. For more information please visit the Sage Author Gateway.

Return to Top

3.3 Contributor’s publishing agreement

International Journal of Clinical Metabolism and Diabetes o ers optional open access publishing via the Sage Choice programme and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with

Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage.

For more information on Open Access publishing options at Sage please visit Sage Open Access. For information on funding body compliance, and depositing your article in repositories, please visit Sage’s Author Archiving and Re-Use Guidelines and Publishing Policies.

Return to Top

4. Preparing your manuscript for submission

4.1 Formatting

The preferred format for your manuscript is Word.

Return to Top

4.2 Artwork, gures and other graphics

For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit Sage’s Manuscript Submission Guidelines

Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For speci cally requested colour reproduction in print, you will receive information regarding the costs from Sage after receipt of your accepted article.

4.3 Supplemental material

This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental les.

4.4 Reference style

International Journal of Clinical Metabolism and Diabetes adheres to the AMA Manual of Style. View the guide here to ensure your manuscript conforms to this style.

Return to Top

5. Submitting your manuscript

International Journal of Clinical Metabolism and Diabetes is hosted on Sage Track Sage, a web based online submission and peer review system.

Visit https://peerreview.sagepub.com/cmd to login and submit your article online.

IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.  For further guidance on submitting your manuscript online please visit Sage Track Sage.

5.1 ORCID

As part of our commitment to ensuring an ethical, transparent and fair peer review process Sage is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identi er that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research work ows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

The collection of ORCID IDs from corresponding authors is now part of the submission process of this Journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all coauthors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID pro le and from there link to your other publications.

If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage to learn more.

5.2 Information required for completing your submission

You will be asked to provide contact details and academic a          liations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The a        liation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new a        liation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary les (including reporting guidelines where relevant).

Return to Top

5.3 Information required for completing your submission

Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, gures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the Sage Author Gateway.

Return to Top

6. On acceptance and publication

6.1. Sage Production

Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via email, and corrections should be made directly or noti ed to us promptly. Authors are reminded to check their proofs carefully to con rm that all author information, including names, a liations, sequence and contact details are correct, and that Funding and Con ict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.

Return to Top

6.2. Online First publication

Online First allows nal articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which signi cantly reduces the lead time between submission and publication. Visit the Sage Journals help page for more details, including how to cite Online First articles.

Return to Top

6.3. Access to your published article

Sage provides authors with online access to their nal article.

6.4. Promoting your article

Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The Sage Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.

Return to Top

7. Further information

Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the International Journal of Clinical Metabolism and Diabetes editorial office as follows:

Dr. Krishna Seshadri (Editor-in-Chief)

E-mail Id: krishnagseshadri@gmail.com